Cargando…

A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial

OBJECTIVES: Outer membrane vesicle (OMV) vaccines are used against outbreaks of capsular group B Neisseria meningitidis (MenB) caused by strains expressing particular PorA outer membrane proteins (OMPs). Ferric enterobactin receptor (FetA) is another variable OMP that induces type-specific bacterici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marsay, L., Dold, C., Green, C.A., Rollier, C.S., Norheim, G., Sadarangani, M., Shanyinde, M., Brehony, C., Thompson, A.J., Sanders, H., Chan, H., Haworth, K., Derrick, J.P., Feavers, I.M., Maiden, M.C., Pollard, A.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	W.B. Saunders 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535279/ https://www.ncbi.nlm.nih.gov/pubmed/25982025 http://dx.doi.org/10.1016/j.jinf.2015.05.006

Ejemplares similares

FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression
por: Sanders, Holly, et al.
Publicado: (2015)

An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity
por: Norheim, Gunnstein, et al.
Publicado: (2015)

Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial
por: Rollier, Christine S., et al.
Publicado: (2022)

Recent Progress in the Prevention of Serogroup B Meningococcal Disease
por: Feavers, Ian M., et al.
Publicado: (2017)

Adjuvant Effects Elicited by Novel Oligosaccharide Variants of Detoxified Meningococcal Lipopolysaccharides on Neisseria meningitidis Recombinant PorA Protein: A Comparison in Mice
por: Mehta, Ojas H., et al.
Publicado: (2014)

Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine
por: Weissmueller, Nikolas T., et al.
Publicado: (2017)

The effect of iron availability on transcription of the Neisseria meningitidis fHbp gene varies among clonal complexes
por: Sanders, Holly, et al.
Publicado: (2012)

Neisseria meningitidis porA, fetA and fHbp gene distribution in Western Australia 2000 to 2011
por: Boan, Peter, et al.
Publicado: (2014)

Comparative transcriptomics between species attributes reactogenicity pathways induced by the capsular group B meningococcal vaccine, 4CMenB, to the membrane-bound endotoxin of its outer membrane vesicle component
por: Sheerin, Dylan, et al.
Publicado: (2019)

Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation
por: Brehony, Carina, et al.
Publicado: (2016)

W135 Meningococcal Disease in Africa
por: Pollard, Andrew J., et al.
Publicado: (2003)

Antigen sequence typing of outer membrane protein (fetA) gene of Neisseria meningitidis serogroup A from Delhi & adjoining areas
por: Dwivedi, S., et al.
Publicado: (2014)

Molecular epidemiology of meningococcal disease in England and Wales 1975–1995, before the introduction of serogroup C conjugate vaccines
por: Russell, Joanne E., et al.
Publicado: (2008)

Meningococcal Deduced Vaccine Antigen Reactivity (MenDeVAR) Index: a Rapid and Accessible Tool That Exploits Genomic Data in Public Health and Clinical Microbiology Applications
por: Rodrigues, Charlene M. C., et al.
Publicado: (2020)

Typing complex meningococcal vaccines to understand diversity and population structure of key vaccine antigens
por: Rodrigues, Charlene M. C., et al.
Publicado: (2019)

Resolution of a Protracted Serogroup B Meningococcal Outbreak with Whole-Genome Sequencing Shows Interspecies Genetic Transfer
por: Mulhall, Robert M., et al.
Publicado: (2016)

Variation in the Neisseria lactamica porin, and its relationship to meningococcal PorB
por: Bennett, Julia S., et al.
Publicado: (2008)

Meningococcal carriage and disease—Population biology and evolution
por: Caugant, Dominique A., et al.
Publicado: (2009)

Haplotypic diversity in human CEACAM genes: effects on susceptibility to meningococcal disease
por: Callaghan, M J, et al.
Publicado: (2007)

Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study
por: Hill, Dorothea M C, et al.
Publicado: (2015)

Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles
por: Daniels-Treffandier, Helene, et al.
Publicado: (2016)

Editorial Commentary: The Endgame for Serogroup A Meningococcal Disease in Africa?
por: Maiden, Martin C. J.
Publicado: (2013)

Factor H binding protein (fHbp)-mediated differential complement resistance of a serogroup C Neisseria meningitidis isolate from cerebrospinal fluid of a patient with invasive meningococcal disease
por: Facchetti, Alessandra, et al.
Publicado: (2021)

Influence of the combination and phase variation status of the haemoglobin receptors HmbR and HpuAB on meningococcal virulence
por: Tauseef, Isfahan, et al.
Publicado: (2011)

Construction of Opa-Positive and Opa-Negative Strains of Neisseria meningitidis to Evaluate a Novel Meningococcal Vaccine
por: Sadarangani, Manish, et al.
Publicado: (2012)

Metabolic shift in the emergence of hyperinvasive pandemic meningococcal lineages
por: Watkins, Eleanor R., et al.
Publicado: (2017)

Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine
por: O’Connor, Daniel, et al.
Publicado: (2020)

Enhancement of low‐fat Feta cheese characteristics using probiotic bacteria
por: Hamdy, Ahmed M., et al.
Publicado: (2020)

Correction: Construction of Opa-Positive and Opa-Negative Strains of Neisseria meningitidis to Evaluate a Novel Meningococcal Vaccine
por: Sadarangani, Manish, et al.
Publicado: (2013)

Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4(+) T Cells
por: Jones, Claire, et al.
Publicado: (2016)

Editorial Commentary: Fifteen Years of Protection by Meningococcal C Conjugate Vaccines: Lessons From Disease Surveillance
por: Maiden, Martin C. J., et al.
Publicado: (2014)

Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis
por: Awanye, Amaka M., et al.
Publicado: (2019)

Variation of the factor H-binding protein of Neisseria meningitidis
por: Brehony, Carina, et al.
Publicado: (2009)

Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022
por: Rodrigues, C. M. C., et al.
Publicado: (2023)

Variation and molecular evolution of HmbR, the Neisseria meningitidis haemoglobin receptor
por: Evans, Nicholas J., et al.
Publicado: (2010)

UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence
por: Bratcher, Holly B., et al.
Publicado: (2019)

The Effect of Immune Selection on the Structure of the Meningococcal Opa Protein Repertoire
por: Callaghan, Martin J., et al.
Publicado: (2008)

Influence of probiotic adjunct cultures on the characteristics of low‐fat Feta cheese
por: Ahmed, Mahmoud E., et al.
Publicado: (2021)

Prevalence and decay of maternal pneumococcal and meningococcal antibodies: A meta-analysis of type-specific decay rates
por: Voysey, Merryn, et al.
Publicado: (2017)

Meningococcal Disease
por: Pollard, Andrew J
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1uekqacahrf3hnv1efge29hiu8